APA Eyes Biomarkers to End Mental Health Guessing Game
The APA is pushing biomarkers into psychiatric diagnosis. Here is what the science actually shows, what it cannot do yet, and why it matters for patients.
Whole genome sequencing is cutting rare disease diagnosis from years to hours. Learn how WGS is transforming patient outcomes and proactive care models.
Dutch WGS Reimbursement Transforms Cancer Care Access
The Netherlands became the first country to fully reimburse whole genome sequencing for cancer patients in 2025. Here is what it means for care access.
CuRe Trial: Stem Cells Boost Fetal Spina Bifida Surgery
The CuRe Trial shows stem cells added to fetal spina bifida surgery may improve motor outcomes and reduce hydrocephalus. Early but compelling Phase 1 results.
Pfizer BREAKWATER Trial Doubles Survival in BRAF Mutant
Pfizer's BREAKWATER trial doubled survival in BRAF V600E-mutant colorectal cancer. FDA approved February 2026. What patients and clinicians need to know.
Why Eli Lilly's Zepbound Just Got FDA Fast Track for Sleep
Eli Lilly's Zepbound becomes the first FDA-approved medication for obstructive sleep apnea in adults with obesity, offering an alternative to CPAP therapy.
